Humoral and cellular immune responses to the SARS‐CoV‐2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls-Reference-Cited by-同舟云学术

Humoral and cellular immune responses to the SARS‐CoV‐2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls

Published:2021-12-21 Issue:1 Volume:24 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transplant Infectious Dis

Author:

Yanis Ahmad¹^ORCID,Haddadin Zaid¹,Spieker Andrew J.²,Waqfi Danya¹,Rankin Danielle A.¹³,Talj Rana¹,Thomas Lora⁴,Birdwell Kelly A.⁴,Ezzell Lauren¹,Blair Marcia¹,Eason Joan¹,Varjabedian Rebekkah¹,Warren Christian M.⁴,Nochowicz Cynthia H.⁴,Olson Eric C.⁴,Simmons Joshua D.⁴,Yoder Sandra¹,Guy Madeline¹,Thomsen Isaac¹,Chappell James D.¹,Kalams Spyros A.⁴⁵,Halasa Natasha B.¹^ORCID

Affiliation:

1. Department of Pediatrics Vanderbilt University Medical Center Nashville Tennessee USA

2. Department of Biostatistics Vanderbilt University Nashville Tennessee USA

3. Vanderbilt Epidemiology PhD Program Vanderbilt University School of Medicine Nashville Tennessee USA

4. Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA

5. Department of Pathology, Microbiology, and Immunology Vanderbilt University Nashville Tennessee USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13772

Reference47 articles.

1. COVID-19 infection in kidney transplant recipients at the epicenter of pandemics

2. Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States

3. An early experience on the effect of solid organ transplant status on hospitalized COVID‐19 patients

4. Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center

5. Current advances in the development of SARS-CoV-2 vaccines

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B and T Cell Responses to SARS-CoV-2 Vaccination in Kidney and Liver Transplant Recipients with and without Previous COVID-19;Viruses;2023-12-19

2. Tixagevimab-Cilgavimab Decreases the Rate of SARS-CoV-2 Infection Among Solid Organ Transplant Recipients;Transplantation Proceedings;2023-10

3. Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan;Vaccine;2023-07

4. Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis;Vaccines;2023-06-27

5. Predominantly defective CD8+ T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients;Journal of Translational Medicine;2023-06-08